Search results for "Peptide-mass fingerprint"

showing 2 items of 2 documents

Shell palaeoproteomics: first application of peptide mass fingerprinting for the rapid identification of mollusc shells in archaeology.

2020

10 pages; International audience; Molluscs were one of the most widely-used natural resources in the past, and their shells are abundant among archaeological findings. However, our knowledge of the variety of shells that were circulating in prehistoric times (and thus their socio-economic and cultural value) is scarce due to the difficulty of achieving taxonomic determination of fragmented and/or worked remains. This study aims to obtain molecular barcodes based on peptide mass fingerprints (PMFs) of intracrystalline proteins, in order to obtain shell identification. Palaeoproteomic applications on shells are challenging, due to low concentration of molluscan proteins and an incomplete unde…

0301 basic medicineFreshwater bivalve[SHS.ARCHEO]Humanities and Social Sciences/Archaeology and PrehistoryBiophysicsShell (structure)BiologyBiochemistryPeptide Mapping03 medical and health sciencesPeptide mass fingerprintingAnimal Shells[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]Mollusc shellMollusc shellAnimalsPeptide mass fingerprintPeptide-mass fingerprintPhylogenyShellomics030102 biochemistry & molecular biologyPhylogenetic treeMALDI-TOF mass spectrometry; Mollusc shell; Palaeoproteomics; Peptide mass fingerprint; ShellomicsMALDI-TOF mass spectrometryPalaeoproteomicsArchaeologyBivalvia030104 developmental biologyTaxonArchaeologyIdentification (biology)Peptides
researchProduct

Characterization of the Proteomic and Genomic Profiles of Chronic Lymphocytic Leukemia Patients with Distinct Clinical Prognosis According to the Mut…

2005

Abstract Introduction: In recent years several molecular prognostic factors have been identified in Chronic Lymphocytic Leukemia B (B-CLL). These include mutations in the variable region of the immunoglobulin genes (IgVH), somatic mutations in the BCL6 gene (Leukemia (2004) 18, 743–746) and the expression level of CD38 and ZAP70. However its biological significance is not clear. In order to identify novel molecular markers with prognostic and therapeutic value we have analyzed the proteomic and genomic profile of 40 B-CLL patients (Binet stage A). Material and methods: 100 μg of total PBMC proteins were used for IEF followed by 2D electrophoresis. Image analysis of scanned gels was used to …

GeneticsMutationTwo-dimensional gel electrophoresisImmunologyCell BiologyHematologyBiologymedicine.disease_causeBiochemistryMolecular biologyGene expression profilingGenomic ProfileGene expressionmedicineHuman genomePeptide-mass fingerprintGeneBlood
researchProduct